<DOC>
	<DOCNO>NCT00826280</DOCNO>
	<brief_summary>Observe whether administration caffeine prior regadenoson affect interpretation test result subject coronary artery disease ( CAD ) undergo SPECT MPI</brief_summary>
	<brief_title>Caffeine 's Effect Regadenoson Administration With Single Photon Emission Computed Tomography ( SPECT ) Myocardial Perfusion Imaging ( MPI )</brief_title>
	<detailed_description>All subject undergo rest stress scan . Those subject qualify demonstrate least 1 reversible defect , undergo third scan . All stress scan involve injection regadenoson pharmacologic stress agent . Prior third scan , subject administer blind capsule placebo caffeine .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Subject must undergone previous diagnostic study [ e.g. , SPECT , echocardiography , magnetic resonance imaging ( MRI ) , etc . ] clinical indication demonstrate evidence reversible defect ≥ 1 vascular segment , stress test within past 3 month , subject 's history suggest least 50 % likelihood CAD If previous diagnostic study show 1 reversible defect segment 17 , another reversible defect need present Subject CAD must intermediate/lowrisk immediate intervention Subject must ingest caffeinated food beverage regularly ( least equivalent one cup caffeinated coffee daily ) Subject must agree ingest caffeine food contain methylxanthine least 24 hour prior study visit Subject must agree abstain eat solid food drinking liquid water least 30 minute prior study visit 30 minute follow study visit Subject document myocardial infarction ( MI ) ≤ 30 day prior enrollment Subject history percutaneous coronary intervention ( PCI ) ≤ 4 week prior enrollment Subject history coronary artery bypass graft ( CABG ) ≤ 8 week prior enrollment Subject prior history heart transplantation Subject unstable angina , know severe left main coronary artery stenosis , severe heart failure , uncontrolled arrhythmia , symptomatic hypotension severe hypertension ( systolic blood pressure &lt; 90 &gt; 180 mmHg , respectively ) , &gt; 1st degree atrioventricular block absence function pacemaker Subject require emergent cardiac medical intervention catheterization Subject history smoking , regardless frequency , tobacco type method intake , use smoke cessation product , include limited nicotine patch nicotine gum , within 3 month prior first dose regadenoson Subject currently undergo treatment theophylline , theophylline contain medication within 7 day prior randomization ( Day 3 ) Subject history know suspected bronchoconstrictive bronchospastic lung disease [ e.g. , asthma , wheeze , chronic obstructive pulmonary disease ( COPD ) , etc . ] Subject history diabetes associate gastric disorder and/or empty Subject end stage renal disease ( ESRD ) GFR &lt; 15mL/min currently undergoing dialysis ESRD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>coronary artery disease ( CAD )</keyword>
	<keyword>ischemia</keyword>
	<keyword>pharmacologic stress</keyword>
</DOC>